| Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan M Mongiat, SM Sweeney, JD San Antonio, J Fu, RV Iozzo Journal of Biological Chemistry 278 (6), 4238-4249, 2003 | 414 | 2003 |
| Extracellular matrix, a hard player in angiogenesis M Mongiat, E Andreuzzi, G Tarticchio, A Paulitti International journal of molecular sciences 17 (11), 1822, 2016 | 245 | 2016 |
| Extracellular matrix: a matter of life and death S Marastoni, G Ligresti, E Lorenzon, A Colombatti, M Mongiat Connective tissue research 49 (3-4), 203-206, 2008 | 226 | 2008 |
| Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis M Mongiat, J Fu, R Oldershaw, R Greenhalgh, AM Gown, RV Iozzo Journal of Biological Chemistry 278 (19), 17491-17499, 2003 | 222 | 2003 |
| The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7 M Mongiat, K Taylor, J Otto, S Aho, J Uitto, JM Whitelock, RV Iozzo Journal of Biological Chemistry 275 (10), 7095-7100, 2000 | 188 | 2000 |
| Fibroblast growth factor-binding protein is a novel partner for perlecan protein core M Mongiat, J Otto, R Oldershaw, F Ferrer, JD Sato, RV Iozzo Journal of Biological Chemistry 276 (13), 10263-10271, 2001 | 171 | 2001 |
| Antitumor activity of gold (III)‐dithiocarbamato derivatives on prostate cancer cells and xenografts L Cattaruzza, D Fregona, M Mongiat, L Ronconi, A Fassina, A Colombatti, ... International Journal of Cancer 128 (1), 206-215, 2011 | 159 | 2011 |
| A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth EM Gonzalez, M Mongiat, SJ Slater, R Baffa, RV Iozzo Journal of Biological Chemistry 278 (40), 38113-38116, 2003 | 146 | 2003 |
| The EMILIN protein family A Colombatti, R Doliana, S Bot, A Canton, M Mongiat, G Mungiguerra, ... Matrix biology 19 (4), 289-301, 2000 | 143 | 2000 |
| The EMILIN/multimerin family A Colombatti, P Spessotto, R Doliana, M Mongiat, GM Bressan, ... Frontiers in immunology 2, 93, 2012 | 128 | 2012 |
| EMILIN, a component of the elastic fiber and a new member of the C1q/tumor necrosis factor superfamily of proteins R Doliana, M Mongiat, F Bucciotti, E Giacomello, R Deutzmann, D Volpin, ... Journal of Biological Chemistry 274 (24), 16773-16781, 1999 | 105 | 1999 |
| MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway E Lorenzon, R Colladel, E Andreuzzi, S Marastoni, F Todaro, ... Oncogene 31 (26), 3136-3147, 2012 | 103 | 2012 |
| Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2 M Mongiat, G Ligresti, S Marastoni, E Lorenzon, R Doliana, A Colombatti Molecular and cellular biology 27 (20), 7176-7187, 2007 | 100 | 2007 |
| CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth N Casagrande, C Borghese, L Visser, M Mongiat, A Colombatti, ... Haematologica 104 (3), 564, 2018 | 91 | 2018 |
| The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis E Andreuzzi, R Colladel, R Pellicani, G Tarticchio, R Cannizzaro, ... Matrix Biology 64, 40-53, 2017 | 75 | 2017 |
| Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium F Galvagni, F Nardi, O Spiga, A Trezza, G Tarticchio, R Pellicani, ... Matrix Biology 64, 112-127, 2017 | 74 | 2017 |
| Self-assembly and supramolecular organization of EMILIN M Mongiat, G Mungiguerra, S Bot, MT Mucignat, E Giacomello, R Doliana, ... Journal of Biological Chemistry 275 (33), 25471-25480, 2000 | 73 | 2000 |
| Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer N Casagrande, M De Paoli, M Celegato, C Borghese, M Mongiat, ... Gynecologic oncology 131 (3), 744-752, 2013 | 69 | 2013 |
| The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment M Mongiat, S Marastoni, G Ligresti, E Lorenzon, M Schiappacassi, ... Neoplasia 12 (4), 294-IN1, 2010 | 63 | 2010 |
| EMILIN2 down‐modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration S Marastoni, E Andreuzzi, A Paulitti, R Colladel, R Pellicani, F Todaro, ... The Journal of pathology 232 (4), 391-404, 2014 | 61 | 2014 |
